Belite Bio

Forecast & Rating8 analysts currently cover Belite Bio, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $210.50, about 32.7% upside from the current price of $158.61. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 67.5% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Belite Bio closely still see room for the stock to rise. Data as of Jul 27, 2026; for reference only and not investment advice.